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Abstract
Cold atmospheric plasma (CAP) is increasingly used in medical applications for eradication of bacterial and tumor
cells. CAP treatment devices, known as plasma jet pens, produce reactive oxygen and nitrogen species at
atmospheric pressure and room temperature. The produced reactive species are concentrated in a small and
precisely defined area, allowing for high precision medical treatments. CAP has been demonstrated as very effective
against planktonic bacterial cells. Unfortunately, bacterial cells in biofilms are typically aggregated and protected by
dense exopolymeric matrix, synthesized and secreted by the bacterial community. The main limitation in using CAP
against bacterial biofilms is the thick protective matrix of extracellular polymers that shields bacterial cells within this
complex architecture. CAP has also been shown to effectively eradicate tumor cells, but the main current limitation is
the susceptibility of the surrounding healthy tissues to higher doses. We have recently demonstrated that vitamin C,
a natural food supplement, can be used to destabilize bacterial biofilms and render them more susceptible to the
CAP killing treatment. Here we discuss the possible impact that a pre-treatment with vitamin C could have on CAP
applications in medicine. Specifically, we argue that vitamin C could enhance the effectiveness of CAP treatments
against both the bacterial biofilms and some selected tumors.
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Cold Atmospheric Plasma and Its Medical Applications
Plasma is defined as the fourth state of matter, but unlike solids,
liquids and gasses, it does not occur under normal temperature and
pressure conditions. Plasma can be generated from neutral gases such
as helium, argon, nitrogen, heliox and atmospheric air by subjecting
them to a strong electromagnetic field [1]. In order to be used in
medical applications, plasma has to be generated at atmospheric
pressure and its temperature must be suitable to treat living tissues (up
to 40°C at the point of application). This special type of plasma is
named cold atmospheric plasma (CAP) [2-4]. CAP is receiving
increasing attention in medical applications due to its high bactericidal
activity and low toxicity towards healthy human cells [5]. CAP
generates reactive oxygen and nitrogen species (RONS), and the
oxidative stress caused by RONS is the killing mechanism that
damages proteins and nucleic acids [6,7]. The CAP sources typically
used for medical treatments are atmospheric pressure plasma jets pens.
The Figure 1 shows a schematic representation of CAP composition
from a plasma jet pen kINPen® MED (Neoplas Control GmbH,
Greifswald, Germany).
Figure 1: Characteristics of CAP produced by kINPen® MED. The
left panel shows the distribution of gas with a degree of ionization
of α=10-3, i.e. containing 10 electrons (blue) and ions (green) for a
total of 104 particles. The right panel shows the electron density
over the plasma gap (arc length) at different times of the production
cycle. The electron density is highest in the plasma bulk since the
free electrons in the plasma have been accelerated to a sufficiently
high kinetic energy to free more electrons from the gas molecules.
In addition, the electron density in the sheath region oscillates with
the applied electric field.
In dental applications, cold plasma is mostly studied for its
antibacterial related activity. In addition to tooth whitening
applications, CAP can be used for a painless restoration of dental
cavities without drilling, root canal disinfection, elimination of
biofilms, bleaching, and treating periodontal and intraoral diseases
caused by bacteria [8]. Although heat treatments and antibiotics can
also be used to eradicate the bacteria, they cause pain and increase risk
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of antibiotic resistance, respectively, and thus CAP represents a
promising alternative. While CAP is used in treatment of root canals
and dental caries, it has been noticed that plasma failed to completely
eradicate bacterial cells hidden in the deeper layers of the biofilm [9].
Extracellular polymeric substances (EPS) produced by bacterial cell
constitute the matrix of the bacterial biofilm, which holds bacterial
communities together. The EPS matrix, which is composed of
polysaccharides, proteins and extracellular DNA, is known to protect
the bacterial communities from various antimicrobial agents, making
them several fold more resistant [10,11]. Generally, the dense
polymeric matrix is protecting the bacterial cells from antimicrobial
exposure by preventing the penetration/diffusion of antimicrobial
molecules. Interestingly, the EPS have also been shown to protect
bacteria from the CAP treatment [12]. It is evident that long CAP
exposure times might have a significant impact on the top layer of cells
in bacterial colonies, but hardly any effect on deeper layers.
Outside dentistry, which arguably represents the broadest field of
CAP use in medicine, CAP is also used to accelerate the haling of
chronic wounds. Chronic wounds, when colonized by bacteria, delay
healing and can foster the development of drug-resistant bacteria with
prolonged antibiotic treatments. CAP not only enhances the wound
healing process but also contains the spread of multi-drug resistant
bacteria [13]. Three to five-day course of cold plasma treatment has
been shown to be required in order to reduce the bacterial load
(Psudomonas aeruginosa) on the wounds [14]. It has been established
that, once the plasma treatment course is stopped, wound-healing also
slows down [14]. Another in vivo study, using a Micro Plaster alpha
device also suggests that wound healing may be accelerated by the
CAP treatment [15]. There are studies which provide insights of the
mechanism by which the Cap treatment stimulates wound healing. It
was reported that CAP treatment influences gene expression of key
regulators that are important for inflammation and wound healing, as
well as activation of antimicrobial peptides [16]. CAP has been clearly
shown to enhance the wound healing effect when used in combination
with certain antiseptic liquids [17]. Therefore, CAP is currently in use
as a decontaminant in hospital environments [18] and for
functionalization of wound dressings [19]. Interestingly, CAP is also
being studied in oncology to eradicate tumor cells. It has been
demonstrated that cold plasma can induce necrosis, apoptosis and cell
detachment by disrupting certain phases of tumor cell replication [20].
CAP effectiveness has been demonstrated against dozens of tumor cell
lines and tumor types in vitro and in vivo, respectively [21]. The
unfortunate limitation in the use of CAP against tumors is that a high
dose CAP exposure can also harm healthy mammalian cells [20],
hence the need for precise micro devices. The recent focus in CAP-
anticancer treatment has thus been on developing small scale and high
precision devices (micro capillaries), which led to successful inhibition
of tumors [22,23].
Combining Vitamin C with Cold Atmospheric Plasma
Vitamin C is a common, natural food supplement which does not
have any clinical side effects. Vitamin C has been reported to be
extremely toxic to Mycobacterium tuberculosis [24], but not to other
common pathogens. There have been reports where vitamin C can be
successfully used to enhance the effect of standard antibiotic
treatments [25,26]. Our group has examined the effect of vitamin C on
bacterial biofilms of that are not killed by vitamin C. We have found
that vitamin C destabilizes their biofilms by inhibiting the production
of the matrix EPS (Pandit & Mijakovic, unpublished results). This leads
to reduction in biofilm complexity and it should enhance the
susceptibility of cells to various anti-microbial agents. Since CAP
treatments are inhibited by the biofilm matrix [12], we have examined
whether vitamin C, which inhibits EPS production, could be used to
enhance the effectiveness of CAP treatments. We found that the
vitamin C pre-treatment made bacterial biofilms of Bacillus subtilis,
Escherichia coli, P. aeruginosa and Staphylococcus epidermidis
significantly more prone to extermination by CAP treatments [27].
These findings are summarized in Figure 2.
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Figure 2: Effect of vitamin C pre-treatment on CAP eradication of a matured bacterial biofilm. The schematics are accompanied with examples
of scanning electron micrographs of Bacillus subtilis. The non-treated biofilm is protected by a thick EPS matrix. Vitamin C pre-treatment
leads to ROS-induced cellular damage, but mainly it eliminates the production of EPS. The CAP treatment successfully eradicates the exposed
bacterial cells by excessive oxidative stress (RONS).
Our results [27] suggest that vitamin C can be used as an effective
pre-treatment, to render CAP treatments more effective. This biofilm-
destabilizing effects probably also accounts for previously reported
effect of vitamin C in enhancing common antibiotic treatments, even
against bacteria which are not directly killed by vitamin C [25,26]. This
suggests that vitamin C could be used as a biofilm destabilizer, to either
enhance the efficiently or reduce the exposure time required in
antibacterial therapy. Reducing exposure and increasing efficiency is
extremely important in capping the growing trend of antibiotic
resistance among common bacterial pathogens.
As previously mentioned, CAP is also used for anticancer therapy
[20-23]. Vitamin C has also been suggested to have adverse effects on
cancer cells [28]. Hypoxia, often encountered in tumors, made multiple
cancer cell lines more susceptible to oxidative damage caused by high
doses of vitamin C [29]. Some colorectal cancers carry specific
mutations that make them specifically sensitive to vitamin C-induced
oxidative stress, i.e. they are selective targets for vitamin C [30]. Given
the proven anticancer effects of vitamin C, there has been an increased
focus on understanding the uptake mechanisms for vitamin C present
in cancer cells [31]. Since CAP and vitamin C both induce ROS and/or
RONS formation in tumor cells, it is plausible to presume that a
combined treatment could more effectively overrun the defenses
against oxidative stress in cancer cells. Therefore we propose that, in
addition to enhancing antibacterial effect of CAP, vitamin C could also
be an effective enhancer of CAP-based anticancer treatments.
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